Polymer Capital Management (Us) LLC Myriad Genetics Inc Transaction History
Polymer Capital Management (Us) LLC
- $388 Billion
- Q1 2025
A detailed history of Polymer Capital Management (Us) LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Polymer Capital Management (Us) LLC holds 13,005 shares of MYGN stock, worth $65,675. This represents 0.03% of its overall portfolio holdings.
Number of Shares
13,005
Previous 13,043
0.29%
Holding current value
$65,675
Previous $179 Million
35.49%
% of portfolio
0.03%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding MYGN
# of Institutions
240Shares Held
95.3MCall Options Held
95.4KPut Options Held
18.2K-
Black Rock Inc. New York, NY15.2MShares$76.5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$53.9 Million0.0% of portfolio
-
State Street Corp Boston, MA5.27MShares$26.6 Million0.0% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN4.73MShares$23.9 Million0.98% of portfolio
-
Wellington Management Group LLP Boston, MA4.59MShares$23.2 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $407M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...